stars 1 stars 2 stars 3

Dynamix is a venture-backed drug discovery and development company focused on cancer and autoimmune disorders. The company’s platform technology, DynamixFit™, is uniquely suitable for discovering novel small-molecule Type II kinase inhibitors that carry the promise of better clinical profiles. Dynamix has created a pipeline of proprietary novel products, and expects to start clinical development in 2011

Dynamix Pharmaceuticals Questions

2 people are employed at Dynamix Pharmaceuticals.

The NAICS codes for Dynamix Pharmaceuticals are [32541, 32, 3254, 325].

The SIC codes for Dynamix Pharmaceuticals are [28, 283].

G2 Leader Summer 2026 G2 Best Est ROI Mid-Market Summer 2026 G2 Easiest Admin Mid-Market Summer 2026 G2 Most Implementable Summer 2026 G2 Best Results Mid-Market Summer 2026 G2 Lead Capture Mid-Market Summer 2026 Inc Fastest Growing Private Companies 2026 Inc Best Workplace 2026
g2crowd
G2Crowd Trusted
chromestore
300K+ Plugin Users